Feasibility, efficacy, safety, and acceptability of mifepristone-misoprostol for medical abortion in the Democratic People's Republic of Korea

International Journal of Gynecology and Obstetrics

Volumn 109, Issue 3, 2010, Pages 209-212

  Tran, Nguyen Toan ^a,b   Jang, Myong Chon ^c   Choe, Yong Su ^c   Ko, Won Suk ^c   Pyo, Hae Suk ^d   Kim, Ok Suk ^d  

^a East Southeast Asia and Oceania Regional Office ^*  (Malaysia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c Korean Family Planning and Maternal and Child Health Association   (North Korea)

^d Pyongyang Maternity Hospital   (North Korea)

Author keywords

Low resource setting; Medical abortion; Mifepristone; Misoprostol; North Korea

Indexed keywords

MIFEPRISTONE; MISOPROST; MISOPROSTOL; MTPILL; UNCLASSIFIED DRUG;

ABDOMINAL CRAMP; ABDOMINAL PAIN; ADULT; ARTICLE; BLEEDING; CHILL; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DRUG EFFICACY; DRUG FEVER; DRUG INDUCED HEADACHE; DRUG SAFETY; FEASIBILITY STUDY; FEMALE; HUMAN; MEDICAL ABORTION; NAUSEA; NORTH KOREA; OUTCOME ASSESSMENT; PAIN; PRIORITY JOURNAL; URBAN RURAL DIFFERENCE; VOMITING;

EID: 77951666464     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijgo.2010.01.012     Document Type: Article

References (26)

1. World Health Organization. Safe Abortion: Technical and Policy Guidance for Health Systems (2003), WHO, Geneva
2. Minority Rights Group International. World Directory of Minorities and Indigenous Peoples - North Korea: Overview (2007), UNHCR, Geneva. http://www.unhcr.org/refworld/docid/4954ce6223.html Available at: http://www.unhcr.org/refworld/docid/4954ce6223.html
3. United Nations Population Fund. State of World Population 2008 (2008), UNFPA, New York. http://www.unfpa.org/swp/2008/includes/images/pdf_swp/notes_indicators_f ull.pdf Available at: http://www.unfpa.org/swp/2008/includes/images/pdf_swp/notes_indicators_f ull.pdf
4. United Nations Population Fund. 2006 Reproductive Health Survey (2006), UNFPA DPRK, Pyongyang
5. UNICEF DPRK. Analysis of the Situation of Children and Women in the Democratic People's Republic of Korea. Pyongyang: UNICEF DPRK; 2006. Available at: http://www.unicef.org/sitan/files/DPRK_Sit_An_2006.pdf.
6. WHO Regional Office for South-East Asia. 11 questions of 11 SEAR Countries (2007), WHO SEARO, New Delhi. http://www.searo.who.int/LinkFiles/Country_Health_System_Profile_3-dprko rea.pdf Available at: www.searo.who.int/LinkFiles/Country_Health_System_Profile_3-dprkorea.pdf
7. Macfarlane S., Racelis M., and Muli-Musiime F. Public health in developing countries. Lancet 356 232 (2000) 841-846
8. World Health Organization. The World Health Report 2006: Working Together for Health (2006), WHO, Geneva
9. Owen-Davies J. North Korea's public health tragedy. Lancet 357 (2001) 628-630
10. Mundle S., Elul B., Anand A., Kalyanwala S., and Ughade S. Increasing access to safe abortion services in rural India: experiences with medical abortion in a primary health center. Contraception 76 1 (2007) 66-70
11. Coyaji K., Elul B., Krishna U., Otiv S., Ambardekar S., Bopardikar A., et al. Mifepristone-misoprostol abortion: a trial in rural and urban Maharashtra, India. Contraception 66 1 (2002) 33-40
12. Winikoff B., Sivin I., Coyaji K.J., Cabezas E., Xiao B., Gu S., et al. Safety, efficacy, and acceptability of medical abortion in China, Cuba, and India: a comparative trial of mifepristone-misoprostol versus surgical abortion. Am J Obstet Gynecol 176 2 (1997) 431-437
13. Winikoff B, Sivin I, Coyaji KJ, Cabezas E, Bilian X, Sujuan G, et al. The acceptability of medical abortion in China, Cuba and India. Int Fam Plann Perspect 1997;23:73-8, 89.
14. Ngoc N.T., Winikoff B., Clark S., Ellertson C., Am K., Hieu D., et al. Safety, efficacy and acceptability of mifepristone-misoprostol medical abortion in Vietnam. Int Fam Plan Perspect 25 (1999) 10-14
15. Karki C., Pokharel H., Kushwaha A., Manandhar D., Bracken H., and Winikoff B. Acceptability and feasibility of medical abortion in Nepal. Int J Gynecol Obstet 106 1 (2009) 39-42
16. World Health Organization Task Force on Post-Ovulatory Methods of Fertility Regulation. Comparison of two doses of mifepristone in combination with misoprostol for early medical abortion: a randomized trial. Br J Obstet Gynaecol 107 4 (2000) 524-530
17. Elul B., Hajri S., Ngoc N.N., Ellertson C., Slama C.B., Pearlman E., et al. Can women in less-developed countries use a simplified medical abortion regimen?. Lancet 357 9266 (2001) 1402-1405
18. Misoprostol for reproductive health: dosage recommendations. In: Weeks A. (Ed). Int J Gynecol Obstet 99(Suppl 2) (2007) S155-S205
19. Tang O.S., Schweer H., Seyberth H.W., Lee S.W., and Ho P.C. Pharmacokinetics of different routes of administration of misoprostol. Hum Reprod 17 2 (2002) 332-336
20. Raghavan S., Comendant R., Digol I., Ungureanu S., Friptu V., Bracken H., et al. Two-pill regimens of misoprostol after mifepristone medical abortion through 63 days' gestational age: a randomized controlled trial of sublingual and oral misoprostol. Contraception 79 2 (2009) 84-90
21. Hajri S., Blum J., Gueddana N., Saadi H., Maazoun L., Chélli H., et al. Expanding medical abortion in Tunisia: women's experiences from a multi-site expansion study. Contraception 70 6 (2004) 487-491
22. Fiala C., Winikoff B., Helström L., Hellborg M., and Gemzell-Danielsson K. Acceptability of home-use of misoprostol in medical abortion. Contraception 70 5 (2004) 387-392
23. Ngoc N.T., Nhan V.Q., Blum J., Mai T.T., Durocher J.M., and Winikoff B. Is home-based administration of prostaglandin safe and feasible for medical abortion? Results from a multisite study in Vietnam. Br J Obstet Gynaecol 111 8 (2004) 814-819
24. Winikoff B., Ellertson C., and Clark S. Analysis of failure in medical abortion. Contraception 54 6 (1996) 323-327
25. Central Bureau of Statistics, Institute of Child Nutrition. DPRK 2004 Nutrition Assessment (2004), Central Bureau of Statistics, Pyongyang. http://www.nautilus.org/napsnet/sr/2005/0587Nutrition.pdf Available at: www.nautilus.org/napsnet/sr/2005/0587Nutrition.pdf
26. Clark W., Gold M., Grossman D., and Winikoff B. Can mifepristone medical abortion be simplified? A review of the evidence and questions for future research. Contraception 75 4 (2007) 245-250